Wert20242025Gesamtverbindlichkeiten79.65 M111.94 MGesamtkapital28.42 M9.46 MGesamtverbindlichkeiten und Eigenkapital108.08 M121.4 MGesamtverschuldung30.16 M30.59 MNettoverschuldung-4.96 M-19.89 M
Fractyl Health Inc
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.